Previous 10 | Next 10 |
OncoCyte (NYSEMKT: OCX ) -46% following unsuccessful results from a clinical validation study of DetermaDx. More news on: OncoCyte Corporation, Zynerba Pharmaceuticals, Inc., Liquidia Technologies, Inc., Stocks on the move, , Read more ...
BOQI International Medical (NASDAQ: BIMI ): Q1 GAAP EPS of -$0.20. More news on: BOQI International Medical Inc., Earnings news and commentary, , Read more ...
NEW YORK, June 29, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced its financial results for the fiscal quarter ended March 31, 2020. "The first quarter was a good start for our healthcare busine...
New York, June 24, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced the closing of the previously announced sale of its legacy energy saving enhancement business. As previously disclosed, on Mar...
New York, June 04, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced the closing of its previously announced sale of $4.45 million of a new series of senior secured convertible notes (the “Con...
New York, May 19, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline on May 19, 2020 by BOQI International Medical Inc. (NASDAQ: BIMI), in the third paragraph, the discount to the amortization conversion price should have been 22%, not 78%. The corrected release follows: ...
New York, May 19, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a securities purchase agreement (the “SPA”) with two institutional investors to sell a ...
BOQI International Medical ( BIMI +10.3% ) has entered into a Memorandum of Understanding to acquire Chongqing Shanfeng Zhiyuan Biotechnology Co., Ltd. through its wholly-owned subsidiary Beijing Xin Rong Xin Industrial Development Co., Ltd. More news on: BOQI International Medical Inc...
New York, May 18, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a Memorandum of Understanding (“MOU”) to acquire Chongqing Shanfeng Zhiyuan Bi...
BOQI International Medical (NASDAQ: BIMI ): FY GAAP EPS of -$0.28. More news on: BOQI International Medical Inc., Earnings news and commentary, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
BIMI International Medical Inc. Company Name:
BIMI Stock Symbol:
NYSE Market:
New York, April 23, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as BIMI International Medical Inc., a healthcare products and services provider, today announced that on April 19, 2024, it received a delin...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) fell 0.7% to $0.177 on volume of 56,661,669 shares INVO BioScience Inc. (INVO) rose 233.6% to $2.535 on volume of 49,222,014 shares WiSA Technologies Inc. (WISA) rose 51.8% to $9.26 on volume of 27,894,316 sh...
New York, Jan. 03, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as (BIMI International Medical Inc.) a healthcare products and services provider, today announced the results of the Company’s 2022 Annual G...